Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Reiber

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|September 7, 2011
The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficientLaszlo Mark, György Paragh, Istvan Reiber
JAMA Cardiology|April 28, 2021
Statin Prescribing and Dosing-Failure Has Become an OptionLaszlo Mark, Istvan Reiber, Peter P Toth
Journal of the American College of Cardiology|April 3, 2012
The good, the bad, and the atherogenicIstvan Reiber, Izabella Mezo, Laszlo Mark, et al.
Archives of Medical Science : AMS|May 20, 2022
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterolIstvan Reiber, Laszlo Mark, Gyorgy Paragh, et al.
Archives of Medical Science : AMS|March 16, 2012
Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008Laszlo Mark, György Paragh, Istvan Karadi, et al.
Archives of Medical Science : AMS|October 12, 2012
How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?Laszlo Mark, György Paragh, Istvan Karadi, et al.
Archives of Medical Science : AMS|February 1, 2012
An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the PLUS ProgramLaszlo Mark, György Paragh, Istvan Karadi, et al.
Atherosclerosis|May 13, 2015
Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in HungaryLaszlo Mark, Antonio J Vallejo-Vaz, Istvan Reiber, et al.
Archives of Medical Science : AMS|July 13, 2013
Persistence with statin therapy in HungaryZoltan Kiss, Laszlo Nagy, Istvan Reiber, et al.
Journal of Clinical Medicine|November 9, 2024
A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in HungaryGergely Gyorgy Nagy, Laszlo Mark, Andrea Gerencser, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|September 7, 2011
The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficientLaszlo Mark, György Paragh, Istvan Reiber
JAMA Cardiology|April 28, 2021
Statin Prescribing and Dosing-Failure Has Become an OptionLaszlo Mark, Istvan Reiber, Peter P Toth
Journal of the American College of Cardiology|April 3, 2012
The good, the bad, and the atherogenicIstvan Reiber, Izabella Mezo, Laszlo Mark, et al.
Archives of Medical Science : AMS|May 20, 2022
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterolIstvan Reiber, Laszlo Mark, Gyorgy Paragh, et al.
Archives of Medical Science : AMS|March 16, 2012
Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008Laszlo Mark, György Paragh, Istvan Karadi, et al.
Archives of Medical Science : AMS|October 12, 2012
How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?Laszlo Mark, György Paragh, Istvan Karadi, et al.
Archives of Medical Science : AMS|February 1, 2012
An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the PLUS ProgramLaszlo Mark, György Paragh, Istvan Karadi, et al.
Atherosclerosis|May 13, 2015
Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in HungaryLaszlo Mark, Antonio J Vallejo-Vaz, Istvan Reiber, et al.
Archives of Medical Science : AMS|July 13, 2013
Persistence with statin therapy in HungaryZoltan Kiss, Laszlo Nagy, Istvan Reiber, et al.
Journal of Clinical Medicine|November 9, 2024
A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in HungaryGergely Gyorgy Nagy, Laszlo Mark, Andrea Gerencser, et al.
Pageof 1